Arcus Biosciences Inc
(RCUS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RCUS | AZN | AMGN | GILD | VRTX |
| Company | Arcus Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.76 | 208.10 | 370.88 | 155.04 | 489.46 |
| High | 19.42 | 211.27 | 374.77 | 155.75 | 494.05 |
| Low | 18.65 | 207.85 | 369.00 | 153.31 | 473.45 |
| Latest | 19.24 | 209.48 | 373.36 | 155.27 | 477.32 |
| Change | +0.32 | +3.93 | +4.17 | +0.29 | -14.15 |
| % Change | +1.69% | +1.91% | +1.13% | +0.19% | -2.88% |
| Volume | 953,300 | 2,287,800 | 2,255,600 | 5,885,100 | 1,721,400 |
| 20-Day Average Volume | 915,405 | 3,255,338 | 3,124,180 | 8,691,645 | 1,636,940 |
| Previous Close | 18.92 | 205.55 | 369.19 | 154.98 | 491.47 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 21.36 | 190.66 | 355.59 | 143.57 | 469.39 |
| 20-Day Raw Stochastic | 11.50% | 94.61% | 81.45% | 94.23% | 64.53% |
| 20-Day Relative Strength | 41.66 | 67.80 | 63.05 | 69.47 | 55.09 |
| Weighted Alpha | +85.62 | +51.43 | +31.71 | +53.29 | +5.29 |
| Today's Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 64% Buy | 100% Buy | 80% Buy | 40% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.94% since 02/09/26 | +11.42% since 02/09/26 | -0.65% since 02/09/26 | +2.37% since 02/09/26 | +1.37% since 02/09/26 |
| Low | 18.65 on 02/17/26 | 190.60 on 02/10/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 454.40 on 02/11/26 |
| High | 21.58 on 02/12/26 | 211.27 on 02/17/26 | 377.36 on 02/10/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 1-Month | |||||
| %Chg | -11.74% since 01/16/26 | +10.97% since 01/16/26 | +13.00% since 01/16/26 | +24.31% since 01/16/26 | +8.15% since 01/16/26 |
| Low | 18.65 on 02/17/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 122.28 on 01/20/26 | 429.00 on 01/20/26 |
| High | 23.78 on 01/22/26 | 211.27 on 02/17/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 3-Month | |||||
| %Chg | -3.75% since 11/17/25 | +17.16% since 11/17/25 | +9.26% since 11/17/25 | +25.13% since 11/17/25 | +9.98% since 11/17/25 |
| Low | 18.65 on 02/17/26 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 418.53 on 11/19/25 |
| High | 26.40 on 12/09/25 | 211.27 on 02/17/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 6-Month | |||||
| %Chg | +85.18% since 08/15/25 | +32.30% since 08/15/25 | +25.94% since 08/15/25 | +31.17% since 08/15/25 | +21.52% since 08/15/25 |
| Low | 9.81 on 08/19/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 26.40 on 12/09/25 | 211.27 on 02/17/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,042,868 | 318,789,152 | 198,801,792 | 192,280,576 | 124,695,272 |
| Shares Outstanding, K | 107,974 | 1,550,908 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 258,000,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -283,000,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 26,000,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -135,000,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.84 | 0.34 | 0.46 | 0.36 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.27 on 10/28/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 02/25/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.25 | 16.76 | 18.63 | 28.32 |